Autophagy-Mediated Inflammatory Cytokine Secretion in Sporadic ALS Patient iPSC-Derived Astrocytes

Abstract

Background. Astrocytes can be involved in motor neuron toxicity in amyotrophic lateral sclerosis (ALS) induced by noncell autonomous effects, and inflammatory cytokines may play the main role in mediating this process. However, the etiology of aberrant cytokine secretion is unclear. The present study assessed possible involvement of the mTOR-autophagy pathway in aberrant cytokine secretion by ALS patient iPSC-derived astrocytes. Method and Results. PBMCs from sporadic ALS patients and control subjects were reprogrammed into iPSCs, which were then differentiated into astrocytes and/or motor neurons. Comparison with control astrocytes indicated that conditioned medium of ALS astrocytes reduced the viability of the control motor neurons ( p < 0.05 ) assessed using the MTT assay. The results of ELISA showed that the concentrations of TNFα, IL1β, and IL6 in cell culture medium of ALS astrocytes were increased ( p < 0.05 ). ALS astrocytes had higher p62 and mTOR levels and lower LC3BII/LC3BI ratio and ULK1 and p-Beclin-1 (Ser15) levels ( p < 0.05 ), indicating defective autophagy. Exogenous inhibition of the mTOR-autophagy pathway, but not the activation of the pathway in control subject astrocytes, increased the levels of p62 and mTOR and concentration of IL-1β, TNF-α, and IL-6 in cell culture medium and decreased the LC3BII/LC3BI ratio and levels of ULK1 and p-Beclin-1 (Ser15), and these changes were comparable to those in ALS astrocytes. After 48 h of rapamycin (autophagy activator) and 3-methyladenine (autophagy inhibitor) treatments, the exogenous activation of the mTOR-autophagy pathway, but not inhibition of the pathway, in ALS astrocytes significantly reduced the concentrations of TNFα, IL1β, and IL6 in cell culture medium and reduced the levels of p62, while increasing the levels of LC3B-II/LC3B-I, ULK1, and p-Beclin-1 (Ser15), and these changes were comparable to those in control subject astrocytes. Conclusion. Alteration in the mTOR/ULK1/Beclin-1 pathway regulated cytokine secretion in ALS astrocytes, which was able to lead to noncell autonomous toxicity. Autophagy activation mitigated cytokine secretion by ALS astrocytes.

SIRT3 enhances the protective effect of Xyloketal B on seizure‐induced brain injury by regulating AMPK/mTOR signaling‐mediated autophagy

“…Therefore, we suggest that SIRT3 is involved in regulating Xyl‐B‐activated autophagy. Autophagy was found to be associated with inflammatory responses, especially the release of IL‐6 and TNF‐α inflammatory mediators 39,40 . Our data suggest that Xyl‐B has regulatory effects on inflammatory factors both in vivo and in vitro, while pretreatment with the autophagy inhibitor 3‐MA reduced the regulatory effects of Xyl‐B on intracellular inflammatory factors.…”

Role of Autophagy Mediated by AMPK/DDiT4/mTOR Axis in HT22 Cells Under Oxygen and Glucose Deprivation/Reoxygenation

“…We further explored the effect of OGD/R on autophagy-related proteins. Beclin1 is an important autophagy regulatory gene that recruits autophagy key protein to autophagic vesicle precursor, forming a complex with Vps34 and Vps15; all of these provide an indispensable condition for the formation of autophagic vesicle . LC3 includes LC3I and LC3II, and LC3II is a marker molecule of autophagic vesicles and serve as a read-out of an autophagic vesicles number .…”

Combined transplantation of hiPSC-NSC and hMSC ameliorated neuroinflammation and promoted neuroregeneration in acute spinal cord injury

“…The derived cells were fixed with 4% paraformaldehyde (Sigma, St. Louis, MO, USA) in DPBS (Invitrogen, Carlsbad, CA, USA) for immunofluorescence staining with the markers nestin and SOX2 [SRY (sex-determining region Y)-box 2] to identify the NSCs. Subsequently, NSCs were cultured in NSC amplification medium [ 30 ]. Passage 3 were used in our experiments.…”